Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aluna developed an FDA-cleared digital spirometer integrated with a mobile app and physician portal to enable daily lung function tracking for asthma, COPD, and cystic fibrosis patients. The system uses proprietary machine learning algorithms to help clinicians identify early signs of respiratory decline, enabling timely intervention. The product is commercially available in the US with insurance coverage under remote patient monitoring codes. As of 2023, over 4,000 active users were reported. In May 2025, the company was acquired by Huma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aluna.